Literature DB >> 2822854

Binding of [3H]Ro 5-4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites.

M Awad1, M Gavish.   

Abstract

The binding of [3H]PK 11195 and [3H]Ro 5-4864 to membrane preparations from cerebral cortex and peripheral tissues of various species was studied. [3H]PK 11195 (0.05-10 nM) bound with high affinity to rat and calf cerebral cortical and kidney membranes. [3H]Ro 5-4864 (0.05-30 nM) also successfully labeled rat cerebral cortical and kidney membranes, but in calf cerebral cortical and kidney membranes, its binding capacity was only 3 and 4%, respectively, of that of [3H]PK 11195. Displacement studies showed that unlabeled Ro 5-4864, diazepam, and flunitrazepam were much more potent in displacing [3H]PK 11195 from rat cerebral cortex and kidney membranes than from calf tissues. The potency of unlabeled Ro 5-4864 in displacing [3H]PK 11195 from the cerebral cortex of various other species was also tested, and the rank order of potency was rat = guinea pig greater than cat = dog greater than rabbit greater than calf. Analysis of these displacement curves revealed that Ro 5-4864 bound to two populations of binding sites from rat and calf kidney and from rat, guinea pig, rabbit, and calf cerebral cortex but to a single population of binding sites from cat and dog cerebral cortex. Using [3H]PK 11195 as a ligand, the rank order of binding capacity in cerebral cortex of various species was cat greater than calf greater than guinea pig greater than rabbit greater than dog greater than rat, whereas when [3H]Ro 5-4864 was used, the rank order of binding capacity was cat greater than guinea pig greater than rat greater than rabbit greater than calf greater than dog.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822854     DOI: 10.1111/j.1471-4159.1987.tb01007.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

1.  Decreases in peripheral-type benzodiazepine receptors in postmortem brains of chronic schizophrenics.

Authors:  A Kurumaji; T Wakai; M Toru
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

2.  Chronological study of peripheral benzodiazepine binding sites in the rat brain stab wounds using [3H] PK-11195 as a marker for gliosis.

Authors:  N Miyazawa; M Diksic; Y Yamamoto
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

3.  Mitochondrial benzodiazepine receptors regulate steroid biosynthesis.

Authors:  A G Mukhin; V Papadopoulos; E Costa; K E Krueger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 4.  On the involvement of a mitochondrial pore in reperfusion injury.

Authors:  M Crompton; L Andreeva
Journal:  Basic Res Cardiol       Date:  1993 Sep-Oct       Impact factor: 17.165

5.  Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation.

Authors:  David R Owen; Owain W Howell; Sac-Pham Tang; Lisa A Wells; Idriss Bennacef; Mats Bergstrom; Roger N Gunn; Eugenii A Rabiner; Martin R Wilkins; Richard Reynolds; Paul M Matthews; Christine A Parker
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-28       Impact factor: 6.200

6.  The effect of chronic treatment with peripheral benzodiazepine receptor ligands on behavior and GABAA/benzodiazepine receptors in rat.

Authors:  L Rägo; V Saano; T Auvinen; A Adojaan; R Holma; M M Airaksinen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

Review 7.  The mitochondrial benzodiazepine receptor: evidence for association with the voltage-dependent anion channel (VDAC).

Authors:  M W McEnery
Journal:  J Bioenerg Biomembr       Date:  1992-02       Impact factor: 2.945

8.  Changes in [3H]-PK 11195 and [3H]-8-OH-DPAT binding following forebrain ischaemia in the gerbil.

Authors:  B A Kenny; A C MacKinnon; M Spedding; C M Brown
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

9.  Neuroprotective properties of lifarizine compared with those of other agents in a mouse model of focal cerebral ischaemia.

Authors:  C M Brown; C Calder; C Linton; C Small; B A Kenny; M Spedding; L Patmore
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

10.  Pharmacological evaluation of [123I]-CLINDE: a radioiodinated imidazopyridine-3-acetamide for the study of peripheral benzodiazepine binding sites (PBBS).

Authors:  Filomena Mattner; Karine Mardon; Andrew Katsifis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-05       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.